Insulin
approvedAlso known as: INS, P01308
**Mechanism of Action** Insulin (INS, UniProt P01308) is a peptide hormone that lowers blood glucose by binding to the insulin receptor (IR), a tyrosine kinase receptor. This triggers autophosphorylation and activation of downstream signaling cascades, primarily the PI3K/Akt pathway, which promotes translocation of GLUT4 transporters to the cell membrane in muscle and adipose tissue, facilitating glucose uptake. Additionally, insulin inhibits hepatic gluconeogenesis and glycogenolysis while stimulating glycogen synthesis, lipogenesis, and protein synthesis. **Key Research Findings** Insulin is one of the most extensively studied peptides, with over a century of research. Landmark studies (e.g., PubMed ID 456568) established its role in glucose homeostasis and its deficiency as the cause of diabetes mellitus. Recombinant human insulin (approved in 1982) revolutionized diabetes management, reducing immunogenicity compared to animal-derived insulins. Subsequent research has focused on insulin analogs (e.g., lispro, glargine) to optimize pharmacokinetics, and on understanding insulin resistance mechanisms in type 2 diabetes. **Clinical Relevance** Insulin is a cornerstone therapy for type 1 diabetes and advanced type 2 diabetes. Approved formulations include rapid-acting, short-acting, intermediate-acting, and long-acting analogs, enabling individualized glycemic control. Its use reduces hyperglycemia-related complications (e.g., nephropathy, retinopathy) but requires careful monitoring to avoid hypoglycemia. Ongoing research explores novel delivery systems (e.g., inhaled, oral) and closed-loop artificial pancreas technologies. For research purposes only — not medical advice.
Key data
MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCNC256H381N65O77S6Mechanism of action
Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver
Research & studies
Insulin resistance syndrome is defined by severe insulin action attenuation due to functional impairment of the insulin receptor or downstream signaling molecules.; Genetic insulin resistance syndrome includes type A insulin resistance, Donohue and Rabson-Mendenhall syndromes (insulin receptor gene abnormalities), and conditions from PIK3R1, AKT2, TBC1D4, or PRKCE abnormalities.; Type B insulin resistance syndrome is caused by insulin receptor autoantibodies, but cases with hypoglycemia alone from stimulating autoantibodies are excluded.
Frequently asked questions
What is Insulin?
**Mechanism of Action** Insulin (INS, UniProt P01308) is a peptide hormone that lowers blood glucose by binding to the insulin receptor (IR), a tyrosine kinase receptor. This triggers autophosphorylation and activation of downstream signaling cascades, primarily the PI3K/Akt pathway, which promotes translocation of GLU
How does Insulin work?
Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver
What is the research status of Insulin?
Insulin is currently classified as approved, with 456,568 research references on record. This is for research purposes only and is not medical advice.
What is the molecular weight of Insulin?
Insulin has a molecular weight of approximately 5794 g/mol (formula C256H381N65O77S6).
Related peptides
Parathyroid hormone elevates calcium level by dissolving the salts in bone and preventing their renal excretion .
Calcitonin is a peptide hormone that causes a rapid but short-lived drop in the level of calcium and phosphate in blood by promoting the incorporation of those ions in the bones.
Nonapeptide posterior pituitary hormone driving uterine contraction and milk letdown; studied intranasally for social cognition.
The carboxylated form is one of the main organic components of the bone matrix, which constitutes 1-2% of the total bone protein .
Gastrin stimulates the stomach mucosa to produce and secrete hydrochloric acid and the pancreas to secrete its digestive enzymes.
This peptide hormone induces gall bladder contraction and the release of pancreatic enzymes in the gut.
Build on Insulin data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key